Keeping You Updated
Charles Macfarlane joins Board of PharmaVentures
Charles Macfarlane joins the Board of PharmaVentures as Non-Executive Director. PharmaVentures assists pharmaceutical and biotechnology companies worldwide in all aspects of deal making.
Fintan Walton, CEO of PharmaVentures says, “I am delighted to be welcoming such a high profile and experienced individual to the Board of PharmaVentures. Charles Macfarlane has sat as an advisor for the Board during the past year and his position as a Director will now provide the company with enormous experience as well as valuable contacts in the industry.”
Charles Macfarlane says, “PharmaVentures is a leading transactions company with whom I look forward to working at a key time in its growth”.
harles’ career with the Procter & Gamble Company spans 40 years, culminating in Heading up the Alliance, Licensing and Acquisition activity of P&G in the Health Care Global Business Unit as Executive Director. In London he was the founding Chairman of British American Business Inc’s. EU Trade and Investment Policy Committee and now serves as the head of the Policy Group. He is a member of the Board and Executive Committee of BABi.
- ends -
Note to Editors
PharmaVentures Limited (http://www.pharmaventures.com) is a leading international corporate advisory firm supporting its clients' growth ambitions in the health care industry. It has considerable experience and expertise in the field of tangible and intangible transactions, providing advice at both a strategic level, as well as acting as advisor and broker at an implementation level. Its transactional experience includes licensing, joint ventures, mergers, acquisitions and divestments. Its clients are worldwide, including Europe, the USA and AsiaPacific. Clients range from start-ups to global pharmaceutical corporations, diversified industrial corporations, investment houses and government bodies. Its subsidiary PharmaTelevision produces the highly popular PharmaDeals® range of intelligence products including analysis tools and reports as well as the world's first dedicated online pharmaceutical television channel PharmaTelevision® (http://www.pharmatelevision.com).
Now in its 18th year, PharmaVentures is based in Oxford, UK, and employs over 30 people.